. Plasma volume is reduced by 10-20% within 24-48 h of expo;l_¢ to simulated or actunl mlcrogravity. Tim clinical impedance of .m.l_rogravity-induced hylx)volemia ismanifcsledby il5 relationxhip with orthostanc |ntoleram:e and reel__ _ed maximal oxygen up_e (VOlta,,) after remm to one gravity (td): .q.ill_ II_tl._h rio ._vldlmc¢ to suggott daa_plasma volume reda_ion duria_ ifii_g_ll/i_ 1_. Mi_Cllllgl with thirlt or renal dysfu_cllanx, a dluresis induced by an iimi_dtgle hk_! volun',_ shift to the central circulation a,ppem'sresponsible for microuavl|y-hlduced byl_wolemi_. Since re.ore actrc_anrs chooxe :_ r_k,'ict their fluid intake before a space mi,ion, ab_nce of increased mine output during actual space flight may be explained by low central venous pressure (CVP) which accompanies dehydration CornI_llh|g evlder_ su_ests thai prolonged reduction in CVP during ¢xposllt_ tO mk'l, ogravtt_," r.etlect_ a "re_etling" to a Iowe_ operating point, which a-'t,_ to limit pnasma volun_expansion during attempt_ toincrease fluid intake. I_gro.ndba_ed and space flight experiments, successful restoralion and maintcnance of plmma volume prior to returning to an upright posture may depend upon development of treatmcnt_ that can retura CVP to it_ baseline IG operatin_ point. Fluid-loadla_ _ Iowu body negative pre_ure (LBNP_ have t_ot proved completely e4_flve In restoring plasma volurae, .mggestJng that they may not provide the sfimttlu_ to elevate the CVP opeeating point. On the othe_ hand, exerclr, e. which canchronically increase CVP, has been effe._Eive inexpanding plasma volume whc, omabined Wlfl! adequate dictum, intake of fluid and ©lecUolytes. _ "/:c_s of d_;gflirlll aqperln_nt_, to under;zand the physiological me,cha.,d_ms of and deeelopn_l_t of _feoive countermeamres for the control of plasma volmne in n_emgrav_ty tald during return to IO will de]penal upon testing that can be conducted under stmtd_-_lized controllad baseline conditions during both ground-based and spaceflight inveJ,iltll_ns, SPACEFLIGHT, Cu/¢rRAL VENOUS PRESSURE. ' In addition to the relationship between plasma volume and aerobic capacity, the hypovo]emia induced by exposure to mierogravity is inversely related to the magnitude of orthostatieally induced tachyeardia, indicating that the larger decrease in blood volume is related to greate_ cardiovascular compromise during an orthostatic challenge (24). The observation that plasma volume alone is not a reliable pred!c_.or of o_lhostatic tolerance after space flight (5) probably reflects the multifactorial etiology of po.q-space Ilight onhostatic hypo_ension. However, it is clear that reduction in inWava_cular volume does contribute to orthostatic problems. Therefore, ¢mphasi,, _hould placed on the development of countermeasures designed to restore plasma volume during microgravity just prior to return to IG for the clinical treatment of post-space 1996.
fiisht compromise to orthostatic competenc_ and physical wor_" perfon_ance.
MECHANISMS OF MICROGRAVITY-INDUCED HYPOVOLEMIA
Reduction in and inability to maintain plasma volume during exposure to microgravity may represent clinical dysfunction of mechanisms associated with fluid intake or renal function. Contrary to this notion, when subjects are allowed to drink ad libitum under exl_rimental conditions controlled tor dietary intake of sodium and calories, their fluid intakes match their urine outputs with the .same magnitude .s pre-exposuw. (Fig. 2) . In addition, sodium, osmotic, and free water renal clearances are similar during exposure to actua] and simulated microgravity compared with ambulatory function (13, 16, 23, 32, 33, 37, 38) .
Thus, with normal balance in fluid intake and output and nonnal renal function throughout exposure to simulated microgravity, there is no evidence to suggest that plasma volume reduction and failure for its maintenance at IO levels during microgravity exposure is associated with clinical dysfunction.
One of the basic mechanisms proposed to explain the reduction in plasma volume during space flight is a pronounced diuresis. It is cleas from ground-based experiments that a rapid diur_sis occurs within the initial 24-48 h of exposure (13, 15, 16, 19, 22) and Ihat the magnitude of this diuresis can account for the amotint of plasma volume reduction (13: Fig. 2 ). Discrepancy conceming this explanation for plasma volume reduction has evolved from the failure of an observable diuresis during actual space flight, a finding that has challenged the validity of ground-based models as being appropriate ar,alogs to investigate the mechanisms underlying microg_avity-induccd hypovolemia. However, dramatic differences between the response of central venous pressure (CVP) during pound-based experiments and space flight may provide a reasonable explanation for the discrepancie._ in diuretic response.
Acute alterations in C'VP can act as a stimulus to alter the rate of urine output. An immediate elevation in C'VP induced by ground-based simulations of microgravity is as._-riated with diuresis (39,42) while the lack of any consistent diuresis during actual space flight occurs in the presence of an immediate reduction in CVP (3). One possible explanation for the discrepancy in CVP and diuretic res'ponses between exposure to actual and simulated microgmvity is that the ground-based model do¢_ not accurately produce the physiological stimulus induced by actual space flight. However, the observation that hypovolemia, as well as numerous other physiological responses, occsrs with sin_lar magnitude under both space flight and simulated conditions (9) is not consistem with this hypothe._is. An alternative explanation is that discrepancies in CVP and dimefic responses between exposure to actual and simulated ]_crogravity reflect a difference in baseline hydration (volemic) state of astronauts. Recent experimenls conducted on nonhuman primates d_ring transient exposures to microgravity induced by parabolic fright in a KC-135 aircraft provided new insight into physiological mechanisms that may be involved in dictating the magnitude of transient changes in CVP during exposure to mierogravity. In the_e experiments, five baboons underwent their exposures to microgravity under three volume states: euvolemic, volume depleted (furosemide and water restriction for 24 h), and volume expanded (osmotic expm_der). Recordings of fight atrial pressure indicated that CVP increased by 4,2 "4-2.9 mm Hg during volume expansion, did not change in the euvolemie state, and decreased by 3.2 -2.2 nun Hg during vohlme depletion (30), It therefore appem_ that the initial hydration state may be critical in determining the change in CVP and subsequently the stimulus for dieresis during the initial period of exposure to microgravity. Compelling evidence exists that crew members undergo volunta. D, dehydration prior to launch in addition to reduced drinking during the initial 48 h of a mix,iondue tospacemotion sickness, which can accountfora reducedurineoutputduringtheinitial week of space flight (31). Akhough un,_uhstantiated by blood volume measurements, it is probable under these condi. dons that astronauts enter their missions in a volumedepleted state that would attenuate initial elevation._ in CVP consistent with space flight measurements (3) and Otflctal Journal of. theAmL,'_m CotbgeofSports Medicine $4,7 eliminate the stimulus for early diuresis. It is therefore reammable to hypothesi_ that an initial elevation in CVP leading to diuresis is a primary mechanism underlying microgravity-induced hypovolemia and that increased CVP aald urineoutputduringactual spaceflight willnot be evident until normalhydration and fluid intake can be maintained in_qtronaut_ immediately prior toandduring theinitial periodofa mission. The apparent dependence of theinitial CVP and renalresponse on thehydration state of astronaut._ underscores the impo 'rtance of designing space flight experiment_ that provide for a controlled baseline condition. Without such controlled baseline conditions, it will he difficult to compare the accuracy by which ground-based analogs simulate the physiological responses associated with _m_ spaceflight and therefore greatly limit ou: capabilities to investigate mechanisms underlying the regulation of plasma volume in microgravity and during return to earth (2).
MECHANISMS OF PLASMA RESTORATION DURING RETURN TO 1G
Relationships between circulating intravascular volume and operational functions of standing and performing physical work suggest that maintenance or replacement of plasma volume should provide clim.'cal u'eatment for orthostatic incompetence and reduced VO,m_,. F..arly space flight experiments demonstrated that both supine and standing heart rates measured immediately after space flight were significantly lower in astronauts who drank approximately 1 1 of isotonic saline within 2 h of reentry from space flight compared with crew members who did nof take the fluid-loading countermeasure (4). These data clearly supported the contention that body fluids (plasma volume) contribute to onhostatie compromise following space flight and that fluid replacement can ameliorate space flight effects. However, data from extended space flight experiments indicated that a.,_the duradon of space flight increases beyond 7-10 d, fluidloading becomes less effective for ameliorating orthostatic compromise following the rrtission (44). The ineffectiveness of fluid-loading to pro_ect orthostatic competence with increased duration of exposure to mi. crogravity may reflect delayed adaptations of autononfic functions associated with b;ood pressure regulation (10-12). In addition, however, data from a ground-based experiment demonstrated that a fluid-loading prescription identical to that implemented by astronauts failed to restore a 15% plasma volume deficit induced by 7 d of head-down tilt (HD'r)(43). Taken together, data from ground-based and space flight experiments suggest that the failure to maintain or replace plasma volume during exposure to microgravity is not limited by fluid.electrolyte intake, but may be dependent upon mechanisms associated with regulation of plasma volume. 
MEDICINE ANDSCIENCE IN SPORTS ANDEXERCISE

Indirect measurements of CVP during ground-based
simulations and actual space flight support the notion that CVP is chronicMly reduced in a similar manner in both conditions of miccogravity (Fig. 3) . With regard to longterm plasma volume regulation during exposures to mierogravity and [estoradon of intrava_ular volume at the end of space missions, this observation may be more significant than the transient decrease that occurs upon entry into orbit (3). lff reduced CVP is merely a reflection of lower plasma volume, then increasing fluid input should be effective in expanding plasma volume to the point where CVP has regained its basefinc level. On the other hand, if the reduction in venous pressure observed during long duration exposure to mJcrogravity represents a "resetting" to a lower operating point, then similar volumes of fluid intake should induce similar volumes of urine excretion.
The concept of a lower operating point is supported by the results of a ground-based experiment (17) where zubject_ who received intravenous itffusion of isotonic saline solution (22 ml,kg-_ body weigh0 showed sindlar urine outputs before compared to the 6th day of HDT (Fig. 4) . This hypothesis is fro'thor supported by the observation that exposure to 7 d of ItDT caused the cardiopulmonary baroreflex stimulus-response relationship to shift to the left so that the responsc for peripheral vascular _sistanc¢ occurred in a Iow,r rangt of central venous pressures (1 l). plasma volume reduction (16% vs 13%. ,x,spectivcly) while chronic exposure to HDT induced a shift to the left along the CVP axis. Further evidence of retorting is provided by the observation that acute pharmacological (fludrocortisone) re._oration of plasma volmne following 7 d of exposure to a _ound-based _alog of microgmvity reduced the slope of tbe cardiopulmor_'y barorcflex stimulus-_respom;¢ relationship to precxposure level, but failed to return the operating range of CVP (43). Taken together, theie comparable data suggest that increased reslmnsiveness of _c baroreflex relationship following adaptation to mlc."ogra_Aty can be primarily explained by hypovolemia while its shiP_ may represent a resetting of the cardiopuimonary baroreflex response to a lower operational range for CVP.
Des'pie the evidence from stirnuhtq-response expertmenU, a physiologic mechanism for explaining the longitudinal "resetting of" the CVP operational point during mierogravity remains unknown, l_umerous brain nuclei and neural pathways have been identified as integrators for processing information from systemic xeceptors for controlling plasma and blood volume. One possible by. pothesis is that extended exposure to microgravity induces long-term adaptation of this "visceral neumaxis" so that tl_ __me levd of CVP (input) from c:ardiopulmonary recep_rs produces a greater renal excretion of water and electrolytes (outpu0, thus changing the processing function of the CNS integrator (26). This hypothesis will remain speculative until future experiments arc designed to investigute the neural plasticity of peripheral and central nervous system mechanisms associated with blood volume regulation.
CLINICAL IMPLICATION OF CVP RESETTING ON FLUID REPLACEMENT
A hypotheais for CVP resetting is illustrated in Figure  6 , The box on the left reprcsems a state of normovolemia under IG conditions. Elevated CTVP resulting from fluid loading will initiate a feedback dit:resis to return CVP to its setpoint. The assumption that flui.-Ikraaling following space flight can successfully restore plasma volume must be based on the assumption thai the prefligh_ CVP reipoint has remained intact. However, similar urine vo:ame rates during saline infusion (17) and faiitire to c "l'la'on ,cally restore and maintain plasma volume during salin,, loading (25,43) observed in human subjects during _posure to ground-based analogs of microgravity supdort the notion that the c.hroaic reduction in CVP refle=ts a change to a low_ olmrat/ng point and that elevated CVP gesulting from fluid loading will initiate a feedbacl: diuresis to return CVP so that plasma volume will remain contracted (the box on the right). Therefore, the attempt to use fluid loading as a countermeasure appears to require an additional stimulus that could reset the CVP operating point to preflight levels.
BASIS FOR DEVELOPMENT OF OUNIOAL COUNTERMEASURE5
LBNP. _ application of lower body negative pressure (LBNP) with fluid loading has been proposed as a means of enhancing plasma volume expansion and retention on the basis that LBNP induces fluid shifts toward the lower extremities in a similar manner to standing in Earth's I G environmenL which in turn reduces CVP and stimulates neuroendoerine secretions associated with fluid and deetrolyt¢ reteution, In a ground-based experiment, six subjects ingested approximately 1 1 of either isotonic _aline alone or ingested the saline after receiving a 4-h exposure to 30 mm Hg of LBNP at the end of 7 d of bed rest (25). Two hours following Ih¢ fluid loading regimens, plasma volume and heart rate and systolic blood pressure responses during a LBNP exposure at 50 nun Hg was measured in each subject. The plasma volume increase frtnn the end of bed re_t to the end of fluid loading was greater with the comb;.nation ot saline load with LBNP (from. 2.80 ± 0.18 to 3.2,t _'L" 0.31 1) compared with .,;aline alone (from 2.81 -+ 0.33 to 3.02 --0.43 1). Likewise, aven_ge systolic blood preasure durin 8 exposure to 50 mm Hg LBNP was maintained at a higher level with the combination of saline load with LBNP compared with saline load (109 *_ 9 ram Hg vs 101 +-11 nan Hg) with a lower average heart rate re_;ponse (89 = 19 bpm vs 100 ± 17 bpm), These results alone provided compelling evidence that LBNP could significantly enhance the replacement and retention of plasma volume and its clinical impact on orthostati¢ stability following exposure to space flight. However. a seldom discussed observation presented in this investigation was the observation that when three of the six subjects were retested with exposure to 50 mm H$ LBN'P after being returned to bed rest for an additional 18 h, average plasma volume (2.94 • 0.19 1) and heart rate response had returned to .tevelsmeasured at the end of 7 d of bed rest before any sal_e loading, Yhese re,_ults suggest that plasma volume expansion induced by combinations of saline loading and LBNF and it_ protective effects oh orthostatic performance _n'e transient and fail to la'ovide effectiveness as a (Fig. 6) , then any attempt to apply a countermeasure f+r prolonged plasma volume expansion in a microgravity environment will require a stimulus that can reset the CVP operating point to preflight levelg. It is possible that emereise provides such a stimulus since exercise-induced hypervolemia is associated with sustained el©ration in CVP (14.41). Re-.setting of CVP by exercise to a higher operating point that alLows plasma volume expansion is fusther supported by the observations that endurance exercise training chronically increased CVP without inhibiting hormones associated with regulation of vascular volume (14) and shiftedthe cardiopulmonary baroreflex stimulus-response relationship to the right so that the response for peripheral vascular resistance occurred in a higher range of central venous presstu:es (35, 36) . If a primary _tech-anism for plasma volume expansion by exercise is elevation of the CVP operating point, then exercise may represent an effective countermeasure treatment to chronically expand and protect plasma volume prior to return to earth from space flight.
The effectiveness of exercise to maintain or restore plasma volume during actual space flight is challenged by the observation that plasma volume is reduced even though astronauts routinely exercise (6, 27, 28) . One conclusion that might be drawn from the_ space flight results is that in the absence of an exercise countermensure in microgravity, hypovolemia would be greater than that observed in astronauts who exercise. This notion is supported by the data presented in Figure 1 , which demonstrates that the magnitude of plasma volume reduction in astronauts who exercised during space flight (27) is less than that reported from a ground-based experiment where subjects did not exercise (10). The inability of current inflight exercise countermeasures to completely restore or defend plasma volume similar to that observed in ground-based experiments may be associated wirh the failure to enhance exerci_-induced hypervolemia with adequate fluid and dietary intake. Thus, efforts to increase fluid and electrolyte intake following exercise may optimize plasma vobame expansion during space flight in crew members.
SUMMARY
A pronounced 10-20% reduction in plasma volume is induced within 2,.)-48 h of exposure to microgravity. The clinical importance of raicrogravity-induce_ hypovolemia is manifested by the relationships between the magnitude of plasma volume reductions and orthostatie intolexance and reduced VOz,_,,x after return to one gravity.
A primary mechanism underlying microgravity-induced hyvwolemia can be explained by an immediate diuresis. Since astronauts choose to restrict their fluid intake immediately before a space mission, the absence of increased urine output during actual space _;.ght may explained by a _reduction in CVP, wb.!ch accompanies dehydration despite an immedi_,.z blood volume shift to the central circulation. Ther_ is no evidePce to suggest that plasma volume r_evtion during expos,:.-, to microgravity is a_:_iated with dysfunction of mechanisms controii ng thirst and renal function. Compelling evidence suggests that prolonged reduction in CVP during exposure to microgravity reflects a "resetting" to a lower operating point, which acts to limit plasma volume expansion during attempts to increase fluid intake. Successful restoration and maintenance of plasma volume prior to returning to the IG environment of earth may depend upon the development of countermeasure treatments that can return CVP to its baseline operating point. Exercise appears to represent such a countermeasure when combined with adequate dietary intake of fluid and electrolyres, Although generally comparable results suggest that ground-based analogs can be used u_ investigate physiological effects of space flight, several important differences in responses have _en consistently reported, Unfortuna,'ely, the inability to systematically control baseline conditions befor-, and during sp_ce flight experiments makes it difficult to verify ground-based models. Therefore, the _uccess of designing experiments to uns SPACEFLIGHT AND PLASM;. VOLUME Offlr..laJJouwnalo_ the American _ o4 _ M_ictne 55]
dcrstand the physiological mechanisms of the control of plasma volume in micmgravity and during return to one gravity will depend upon testing that can be conducted under stanO_dized controlled baseline conditions during both gro,d;M-based and space flight investigations.
